Imbio PHA (4.0.0) vs PMcardio
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary need is the automated, quantitative assessment of cardiac structures from CT pulmonary angiogram (CTPA) scans. This tool excels at measuring right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculating RV/LV and PA/Ao ratios to aid in diagnosing and risk stratifying pulmonary embolism and hypertension. It's ideal for radiologists and cardiologists who require rapid, standardized analysis of CTPA images to assess right ventricular dilation and integrate these findings into existing DICOM workflows.
View Imbio PHA (4.0.0) →Choose PMcardio if…
Choose PMcardio if your focus is on rapid, AI-powered interpretation of electrocardiograms (ECGs) for a broad range of cardiac conditions at the point of care. This tool is particularly well-suited for emergency medicine, internal medicine, and cardiology professionals who need instant, expert-level ECG analysis to detect over 50 cardiac conditions, including STEMI/OMI and reduced LVEF. Its mobile app and web platform deployment, along with features like AI explainability and integration with EHR/CViS, make it valuable for quick clinical decision-making and bridging skills gaps in ECG interpretation.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | PMcardio |
|---|---|---|
| Pricing | Unknown | Freemium |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Pending AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app and web platform, allowing clinicians to start using it immediately without IT integration. It emphasizes a user-friendly experience with instant AI-powered ECG interpretations and visual explainability. Imbio PHA, while automated, is integrated into existing PACS workflows, which might require more initial setup and familiarity with radiology systems.
Clinical Value
PMcardioPMcardio is clinically validated in over 25 studies, detecting 50+ cardiac conditions, including STEMI/OMI and reduced LVEF, and has shown to reduce door-to-balloon times and false positive cath lab activations. Imbio PHA focuses on automated measurements from CTPA scans to assess right ventricular dilation for pulmonary embolism and hypertension, which is valuable but more narrowly focused.
Pricing & Value
PMcardioPMcardio offers a freemium model with a free plan for individuals (5 free ECG analyses per month) and transparent pricing for its Pro plan. Imbio PHA requires direct contact for pricing, making its value proposition less transparent for potential users.
Enterprise Readiness
PMcardioPMcardio is designed for enterprise deployment with integrations into EHR/CVIS and EMS systems, offering unified AI models, end-to-end pathway coverage, and robust security and compliance certifications (SOC 2 Type II, ISO 27001, GDPR, HIPAA). Imbio PHA offers deployment flexibility (cloud, on-premise, partners) and HIPAA compliance, but PMcardio's explicit focus on comprehensive enterprise integration and care coordination across multiple pathways gives it an edge.
Innovation
PMcardioPMcardio demonstrates broader innovation by interpreting ECGs for over 50 cardiac conditions, including advanced features like Queen of Heartsu2122 for STEMI/OMI detection, LVsenseu2122 for reduced LVEF, and ECGxplainu2122 for visual AI explainability. Imbio PHA's innovation lies in its automated measurement of cardiac structures from CTPA scans, which is a specialized application of AI in imaging.
Support & Docs
TieBoth tools provide documentation and support. PMcardio offers a Help Center with articles on getting started, using the app, and FAQs, along with regulatory and security information. Imbio PHA's documentation includes user manuals and information on clinical performance validation. Without more detailed information on the breadth and responsiveness of their support channels, it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | PMcardio |
|---|---|---|
| Name | Imbio PHA (4.0.0) | PMcardio |
| Company | Imbio (a subsidiary of 4DMedical) | Powerful Medical |
| Tagline | Transforming Imaging with AI. | AI that reads ECGs in seconds |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Features (Examples) | Automated measurement of right and left ventricle diameters, Generates annotated DICOM images, Provides summary reports in PDF format | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings, Visual AI Explainability with heatmaps |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and PMcardio.